This project will focus on the translation applications of patient-specific pluripotent stem cell lines. Stem cells offer unique opportunities for setting up novel disease modeling and drug discovery assays. This project will particularly focused on utilizing embryonic as well as induced pluripotent stem cells to study neurodegenerative diseases such as ALS.
|Effective start/end date||11/1/14 → 12/31/16|
- Columbia University (AGMT FE 1/20/16)